Matthew Emmens, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 9,735 shares at $55.51 ($540K) on 2011-05-25, disclosed to the SEC on 2011-05-26.
Open-market sale of $540k VRTX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |